NLS Pharma Business

The acquisition adds expertise and a next generation gene therapy platform to LEO Pharma’s pipeline through Replay’s high‑payload herpes simplex virus (HSV) delivery vector.

The company's PPD Clinical Research Business is opening a new bioanalytical and biomarker laboratory within GoCo Health Innovation City.

It has been approved as the first and only aldosterone synthase inhibitor treatment for adults with hypertension.

The Center for the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has exercised additional options valued at USD 97 million under the existing contract to supply a freeze-dried formulation of JYNNEOS smallpox vaccine.

Diamyd Medical has announces that the initial phase of the strategic review, initiated following the discontinuation of the Phase 3 DIAGNODE-3 trial, has been completed.

The company has established manufacturing capacity in accordance with current quality requirements and regulatory guidelines, it states.